{"id":"https://openalex.org/W1972284669","doi":"https://doi.org/10.1097/iae.0b013e31822529e2","title":"THREE TREATMENTS FOR MACULAR EDEMA BECAUSE OF BRANCH RETINAL VEIN OCCLUSION","display_name":"THREE TREATMENTS FOR MACULAR EDEMA BECAUSE OF BRANCH RETINAL VEIN OCCLUSION","publication_year":2011,"publication_date":"2011-07-30","ids":{"openalex":"https://openalex.org/W1972284669","doi":"https://doi.org/10.1097/iae.0b013e31822529e2","mag":"1972284669","pmid":"https://pubmed.ncbi.nlm.nih.gov/21811207"},"language":"en","primary_location":{"id":"doi:10.1097/iae.0b013e31822529e2","doi":"https://doi.org/10.1097/iae.0b013e31822529e2","is_oa":false,"landing_page_url":"https://doi.org/10.1097/iae.0b013e31822529e2","pdf_url":null,"source":{"id":"https://openalex.org/S19572933","display_name":"Retina","issn_l":"0275-004X","issn":["0275-004X","1539-2864"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Retina","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015030694","display_name":"Kazuyuki Kumagai","orcid":"https://orcid.org/0009-0005-1073-7553","observed_orcids":["https://orcid.org/0009-0005-1073-7553"]},"institutions":[{"id":"https://openalex.org/I17194813","display_name":"Miyazaki Prefectural Nursing University","ror":"https://ror.org/04vh2cv64","country_code":"JP","type":"education","lineage":["https://openalex.org/I17194813"]},{"id":"https://openalex.org/I4405253161","display_name":"Shinjo Ophthalmologic Institute","ror":"https://ror.org/00c5pmp34","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4405253161"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuyuki Kumagai","raw_affiliation_strings":["Shinjo Ophthalmologic Institute, Mego Shimokitakata-machi, Miyazaki, Japan. kazukuma3313@yahoo.co.jp","From the *Shinjo Ophthalmologic Institute, Mego Shimokitakata-machi, Miyazaki, Japan; and \u2021Miyazaki Prefectural Nursing University, Manabino, Miyazaki, Japan.; \u2020Department of Ophthalmology, Kami-iida First General Hospital, Kami-iida kita-machi, Kitaku, Nagoya, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shinjo Ophthalmologic Institute, Mego Shimokitakata-machi, Miyazaki, Japan. kazukuma3313@yahoo.co.jp","institution_ids":["https://openalex.org/I4405253161"]},{"raw_affiliation_string":"From the *Shinjo Ophthalmologic Institute, Mego Shimokitakata-machi, Miyazaki, Japan; and \u2021Miyazaki Prefectural Nursing University, Manabino, Miyazaki, Japan.; \u2020Department of Ophthalmology, Kami-iida First General Hospital, Kami-iida kita-machi, Kitaku, Nagoya, Japan","institution_ids":["https://openalex.org/I17194813","https://openalex.org/I4405253161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112643368","display_name":"Nobuchika Ogino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I17194813","display_name":"Miyazaki Prefectural Nursing University","ror":"https://ror.org/04vh2cv64","country_code":"JP","type":"education","lineage":["https://openalex.org/I17194813"]},{"id":"https://openalex.org/I4405253161","display_name":"Shinjo Ophthalmologic Institute","ror":"https://ror.org/00c5pmp34","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4405253161"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Nobuchika Ogino","raw_affiliation_strings":["From the *Shinjo Ophthalmologic Institute, Mego Shimokitakata-machi, Miyazaki, Japan; and \u2021Miyazaki Prefectural Nursing University, Manabino, Miyazaki, Japan.; \u2020Department of Ophthalmology, Kami-iida First General Hospital, Kami-iida kita-machi, Kitaku, Nagoya, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the *Shinjo Ophthalmologic Institute, Mego Shimokitakata-machi, Miyazaki, Japan; and \u2021Miyazaki Prefectural Nursing University, Manabino, Miyazaki, Japan.; \u2020Department of Ophthalmology, Kami-iida First General Hospital, Kami-iida kita-machi, Kitaku, Nagoya, Japan","institution_ids":["https://openalex.org/I17194813","https://openalex.org/I4405253161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021386683","display_name":"Mariko Furukawa","orcid":"https://orcid.org/0000-0002-0145-1407","observed_orcids":["https://orcid.org/0000-0002-0145-1407"]},"institutions":[{"id":"https://openalex.org/I17194813","display_name":"Miyazaki Prefectural Nursing University","ror":"https://ror.org/04vh2cv64","country_code":"JP","type":"education","lineage":["https://openalex.org/I17194813"]},{"id":"https://openalex.org/I4405253161","display_name":"Shinjo Ophthalmologic Institute","ror":"https://ror.org/00c5pmp34","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4405253161"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mariko Furukawa","raw_affiliation_strings":["From the *Shinjo Ophthalmologic Institute, Mego Shimokitakata-machi, Miyazaki, Japan; and \u2021Miyazaki Prefectural Nursing University, Manabino, Miyazaki, Japan.; \u2020Department of Ophthalmology, Kami-iida First General Hospital, Kami-iida kita-machi, Kitaku, Nagoya, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the *Shinjo Ophthalmologic Institute, Mego Shimokitakata-machi, Miyazaki, Japan; and \u2021Miyazaki Prefectural Nursing University, Manabino, Miyazaki, Japan.; \u2020Department of Ophthalmology, Kami-iida First General Hospital, Kami-iida kita-machi, Kitaku, Nagoya, Japan","institution_ids":["https://openalex.org/I17194813","https://openalex.org/I4405253161"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074540838","display_name":"Eric Edwin Larson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I17194813","display_name":"Miyazaki Prefectural Nursing University","ror":"https://ror.org/04vh2cv64","country_code":"JP","type":"education","lineage":["https://openalex.org/I17194813"]},{"id":"https://openalex.org/I4405253161","display_name":"Shinjo Ophthalmologic Institute","ror":"https://ror.org/00c5pmp34","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4405253161"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Eric Larson","raw_affiliation_strings":["From the *Shinjo Ophthalmologic Institute, Mego Shimokitakata-machi, Miyazaki, Japan; and \u2021Miyazaki Prefectural Nursing University, Manabino, Miyazaki, Japan.; \u2020Department of Ophthalmology, Kami-iida First General Hospital, Kami-iida kita-machi, Kitaku, Nagoya, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the *Shinjo Ophthalmologic Institute, Mego Shimokitakata-machi, Miyazaki, Japan; and \u2021Miyazaki Prefectural Nursing University, Manabino, Miyazaki, Japan.; \u2020Department of Ophthalmology, Kami-iida First General Hospital, Kami-iida kita-machi, Kitaku, Nagoya, Japan","institution_ids":["https://openalex.org/I17194813","https://openalex.org/I4405253161"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.4497,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.80099373,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"32","issue":"3","first_page":"520","last_page":"529"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9771000146865845,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9771000146865845,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.01889999955892563,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/macular-edema","display_name":"macular edema","score":0.8889999985694885},{"id":"https://openalex.org/keywords/branch-retinal-vein-occlusion","display_name":"branch retinal vein occlusion","score":1.0},{"id":"https://openalex.org/keywords/intravitreal-bevacizumab","display_name":"intravitreal bevacizumab","score":0.968999981880188},{"id":"https://openalex.org/keywords/tissue-plasminogen-activator","display_name":"tissue plasminogen activator","score":0.9539999961853027},{"id":"https://openalex.org/keywords/vitrectomy","display_name":"vitrectomy","score":0.968999981880188},{"id":"https://openalex.org/keywords/best-corrected-visual-acuity","display_name":"best-corrected visual acuity","score":0.8759999871253967},{"id":"https://openalex.org/keywords/foveal-thickness","display_name":"foveal thickness","score":0.9800000190734863},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.847000002861023},{"id":"https://openalex.org/keywords/thrombolysis","display_name":"thrombolysis","score":0.6060000061988831},{"id":"https://openalex.org/keywords/treatment-comparison","display_name":"treatment comparison","score":0.32499998807907104}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8868478536605835},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.77088463306427},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.7478949427604675},{"id":"https://openalex.org/C2781242345","wikidata":"https://www.wikidata.org/wiki/Q924295","display_name":"Vitrectomy","level":3,"score":0.7475579977035522},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.7244716286659241},{"id":"https://openalex.org/C2780347916","wikidata":"https://www.wikidata.org/wiki/Q1813737","display_name":"Macular edema","level":3,"score":0.7224479913711548},{"id":"https://openalex.org/C2780261187","wikidata":"https://www.wikidata.org/wiki/Q4956400","display_name":"Branch retinal vein occlusion","level":4,"score":0.637146532535553},{"id":"https://openalex.org/C2776572282","wikidata":"https://www.wikidata.org/wiki/Q416351","display_name":"Tissue plasminogen activator","level":2,"score":0.5611253380775452},{"id":"https://openalex.org/C2908732032","wikidata":"https://www.wikidata.org/wiki/Q5062148","display_name":"Retinal Vein","level":3,"score":0.4816776216030121},{"id":"https://openalex.org/C2780827179","wikidata":"https://www.wikidata.org/wiki/Q422001","display_name":"Retinal","level":2,"score":0.4456857442855835},{"id":"https://openalex.org/C2779736970","wikidata":"https://www.wikidata.org/wiki/Q865103","display_name":"Fovea centralis","level":4,"score":0.4239847660064697},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3789615035057068},{"id":"https://openalex.org/C30181142","wikidata":"https://www.wikidata.org/wiki/Q865103","display_name":"Foveal","level":3,"score":0.3440060019493103},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.06635123491287231},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.055812686681747437}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005343","descriptor_name":"Fibrinolytic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008269","descriptor_name":"Macular Edema","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D008269","descriptor_name":"Macular Edema","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D008269","descriptor_name":"Macular Edema","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010959","descriptor_name":"Tissue Plasminogen Activator","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D012044","descriptor_name":"Regression Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012170","descriptor_name":"Retinal Vein Occlusion","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014792","descriptor_name":"Visual Acuity","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D014821","descriptor_name":"Vitrectomy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D058449","descriptor_name":"Intravitreal Injections","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/iae.0b013e31822529e2","doi":"https://doi.org/10.1097/iae.0b013e31822529e2","is_oa":false,"landing_page_url":"https://doi.org/10.1097/iae.0b013e31822529e2","pdf_url":null,"source":{"id":"https://openalex.org/S19572933","display_name":"Retina","issn_l":"0275-004X","issn":["0275-004X","1539-2864"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Retina","raw_type":"journal-article"},{"id":"pmid:21811207","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21811207","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Retina (Philadelphia, Pa.)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W16060373","https://openalex.org/W140994625","https://openalex.org/W201121852","https://openalex.org/W221049470","https://openalex.org/W1509975549","https://openalex.org/W1965151770","https://openalex.org/W1978037771","https://openalex.org/W1978100914","https://openalex.org/W1978190853","https://openalex.org/W1978704499","https://openalex.org/W1981783036","https://openalex.org/W1983918010","https://openalex.org/W1985530242","https://openalex.org/W1988493298","https://openalex.org/W1999134848","https://openalex.org/W2003640321","https://openalex.org/W2016138786","https://openalex.org/W2023340561","https://openalex.org/W2025722463","https://openalex.org/W2029985752","https://openalex.org/W2031269803","https://openalex.org/W2040037866","https://openalex.org/W2042625705","https://openalex.org/W2046232272","https://openalex.org/W2046885395","https://openalex.org/W2052892208","https://openalex.org/W2054551550","https://openalex.org/W2059129500","https://openalex.org/W2068100937","https://openalex.org/W2071322531","https://openalex.org/W2076065301","https://openalex.org/W2083256895","https://openalex.org/W2084394581","https://openalex.org/W2085947188","https://openalex.org/W2087355096","https://openalex.org/W2087885644","https://openalex.org/W2098283223","https://openalex.org/W2126501086","https://openalex.org/W2128701654","https://openalex.org/W2138088180","https://openalex.org/W2148869970","https://openalex.org/W2153587586","https://openalex.org/W2168858270","https://openalex.org/W2344323145","https://openalex.org/W2767447900","https://openalex.org/W3119921937","https://openalex.org/W4229761845","https://openalex.org/W4243694564","https://openalex.org/W4297917733"],"related_works":["https://openalex.org/W2130940350","https://openalex.org/W2007190043","https://openalex.org/W2937626478","https://openalex.org/W2096282588","https://openalex.org/W2315896448","https://openalex.org/W1978100914","https://openalex.org/W2790246235","https://openalex.org/W1026378313","https://openalex.org/W1989523910","https://openalex.org/W2044684391"],"abstract_inverted_index":{"In":[0],"Brief":[1],"Purpose:":[2],"To":[3],"evaluate":[4],"the":[5,18,68,78,136,139,144,157,166,212,227,234,262],"effectiveness":[6],"of":[7,36,44,60,63,100,109,117,226,233,243],"intravitreous":[8,11,45,110,158,193,255],"bevacizumab":[9,64,111,159,194,256],"(Avastin),":[10],"tissue":[12,50,167,196,218,258],"plasminogen":[13,51,168,197,219,259],"activator,":[14,52,198,220,260],"and":[15,53,70,82,126,135,161,203,221,230,261],"vitrectomy":[16,222],"for":[17],"macular":[19,240],"edema":[20,241],"secondary":[21],"to":[22,103,119,179,210,224],"branch":[23,244],"retinal":[24,245],"vein":[25,246],"occlusion.":[26,247],"Methods:":[27],"Retrospective,":[28],"interventional":[29],"case":[30],"series.":[31],"We":[32],"studied":[33],"228":[34,37],"eyes":[35,40,48,55,154,163,190,238,250],"patients.":[38],"Forty-one":[39],"received":[41,49],"1.25":[42,61],"mg":[43,62],"bevacizumab,":[46,216],"71":[47],"116":[54],"underwent":[56],"vitrectomy.":[57],"A":[58],"reinjection":[59],"was":[65,94,112,208],"based":[66],"on":[67],"morphologic":[69],"functional":[71],"findings.":[72],"The":[73,89,106,121,175],"main":[74],"outcome":[75],"measures":[76],"were":[77,147,201],"best-corrected":[79,123,140],"visual":[80,124,141,182,228],"acuity":[81,125,142,229],"optical":[83],"coherence":[84],"tomography\u2013determined":[85],"foveal":[86,127,235],"thickness.":[87],"Results:":[88],"mean":[90,107,122],"postoperative":[91],"follow-up":[92,206],"period":[93,207],"32.2":[95],"months":[96,102],"with":[97,114,192,239],"a":[98,115,204,231],"range":[99,116],"12":[101,151,185],"69":[104],"months.":[105,152,186],"number":[108],"2.8":[113],"1":[118],"5.":[120],"thickness":[128,236],"significantly":[129],"improved":[130],"after":[131,254],"all":[132],"3":[133,145,176],"treatments,":[134],"differences":[137],"in":[138,156,165,188,237],"between":[143],"groups":[146],"not":[148],"significant":[149],"at":[150,184],"Fourteen":[153],"(34%)":[155],"group":[160,170],"21":[162],"(30%)":[164],"activator":[169],"required":[171,209,251],"additional":[172,199,252],"surgeries.":[173],"Conclusion:":[174],"treatments":[177],"appear":[178],"provide":[180],"similar":[181],"outcomes":[183,264],"However,":[187,248],"some":[189,249],"treated":[191],"or":[195,257],"surgeries":[200,253],"required,":[202],"longer":[205],"determine":[211],"final":[213],"outcome.":[214],"Intravitreous":[215],"intravitreal":[217],"led":[223],"improvements":[225],"reduction":[232],"because":[242],"long-term":[263],"are":[265],"undetermined.":[266]},"counts_by_year":[{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}